Tecartus ™ yog FDA-pom zoo tshuaj tiv thaiv kab mob - kev kho mob tsim los pab koj lub cev tiv thaiv kab mob tiv thaiv kab mobTshwj xeeb, nws yog hom chimeric antigen receptor (CAR) T- cell kho. Nws ntxiv dag zog rau koj cov hlwb T, cov qe ntshav dawb tshwj xeeb hauv koj lub cev uas muaj lub zog los rhuav tshem cov qog nqaij hlav cancer.
Tecartus siv rau dab tsi?
TECARTUS yog kho rau koj cov qog ntshav qog ntshav qog ntshav Nws yog siv tom qab kis kab mob thaum nyob lossis tom qab lwm yam kev kho mob. TECARTUS txawv dua li lwm cov tshuaj kho mob qog noj ntshav vim nws yog tsim los ntawm koj tus kheej cov qe ntshav dawb, uas tau hloov kho kom paub txog thiab tua koj cov qog ntshav qog ntshav.
Yescarta lub hom phiaj yog dab tsi?
Yescarta yog qhia rau kev kho mob ntawm cov neeg laus nrog relapsed lossis refractory diffuse loj B-cell lymphoma (DLBCL) thiab thawj mediastinal loj B-cell lymphoma (PMBCL), tom qab ob lossis ntau kab ntawm kev kho mob.
Kymriah lossis Yescarta twg zoo dua?
“ Kymriah muaj tau qhia ntau dua ntawm Qib ¾ CRS [cytokine release syndrome}, hos Yescarta cuam tshuam nrog qib siab dua qib ¾ cov xwm txheej hauv paj hlwb, ob qho tib si cov xwm txheej tsis zoo nrog CAR-T kev kho mob. "
Qhov txawv ntawm Tecartus thiab Yescarta yog dab tsi?
Thaum Tecartus qhia tib tus qauv tsim raws li Yescarta, kuj yog tsim los ntawm Kite Pharma, Inc., qhov sib txawv yog hauv cov txheej txheem tsimTecartus tau dhau los ua cov txheej txheem ntawm cov qe ntshav dawb, uas Nws yog ib qho tsim nyog rau qee hom kab mob B-hlwb cov ntshav, xws li MCL, qhov twg cov lymphoblasts circulating yog ib qho zoo heev.
